Complete response of metastatic alveolar soft part sarcoma in an adolescent female treated by combined immune checkpoint inhibitors

Pediatr Blood Cancer. 2022 Dec;69(12):e29787. doi: 10.1002/pbc.29787. Epub 2022 May 20.

Authors

Youngeun Jung¹, Ye Jee Shim¹, Hye Ra Jung², Heung Sik Kim³

Affiliations

¹ Department of Pediatrics, Keimyung University School of Medicine, Keimyung University Dongsan Hospital, Daegu, Republic of Korea.
² Department of Pathology, Keimyung University School of Medicine, Keimyung University Dongsan Hospital, Daegu, Republic of Korea.
³ Department of Pediatrics, Keimyung University School of Medicine, Keimyung University Daegu Dongsan Hospital, Daegu, Republic of Korea.

PMID: 35593032
DOI: 10.1002/pbc.29787

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Female
Humans
Immune Checkpoint Inhibitors
Neoplasms, Second Primary*
Sarcoma, Alveolar Soft Part* / drug therapy
Sarcoma, Alveolar Soft Part* / pathology
Soft Tissue Neoplasms* / pathology

Substances

Immune Checkpoint Inhibitors